Table 1.

Incidence of hyperplasia and PIN lesions in VP and DP of PB-PKC transgenic mice

			Ventral prostate		Dorsal prostate
Mice	Age (months)	n	Hyperplasia, number (%)	PIN, number (%)	Hyperplasia, number (%)	PIN, number (%)
Wild-type	12	14	0 (0%)	0 (0%)	0 (0%)	0 (0%)
PB-PKCα	12	8	1 (12%)*	0 (0%)	1 (12%)*	0 (0%)
PB-PKCδ	12	6	1 (8%)	0 (0%)	0 (0%)	0 (0%)
PB-PKCε	8	7	7 (100%)	6 (86%)	6 (86%)	5 (71%)
PB-PKCε	12	17	17 (100%)	17 (100%)	17 (100%)	17 (100%)
PB-PKCε	14	4	4 (100%)	4 (100%)	4 (100%)	4 (100%)
PB-PKCε	16	3	3 (100%)	3 (100%)	3 (100%)	3 (100%)

^*Mild hyperplasia.